	Independent evaluation of machine learning and deep learning models for breast cancer detection. PLOS Digit Health Deepthi, Nayak A, Panicker RO. PMID: 42804475 [PubMed]
	Risk-reducing salpingo-oophorectomy in patients with gBRCA-mutated breast cancer. Arch Gynecol Obstet Amann N, Wagner K, Ziegler P, Krückel A, Brückner L, Gocke J, Müller C, Runz C, Heindl F, Hack CC, Emons J, Fasching AP, Beckmann WM, Hörner M. PMID: 42804048 [PubMed - indexed for MEDLINE]
	Circulating tumour DNA and its clinical relevance in predicting progression-free survival and overall survival in patients with advanced breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat Ottosen C, Kragelund E, Pedersen MA, Nguyen VQ, Khan SK, Larsen HB, Møller AL, Gamborg-Kvist SH, Spindler KG, Brems-Eskildsen AS, Callesen LB. PMID: 42804029 [PubMed - indexed for MEDLINE]
	Dermatologic adverse events associated with Sacituzumab Govitecan: an international retrospective study from the EADV Task Force "Dermatology for Cancer Patients" and pharmacovigilance analysis. Breast Cancer Res Treat Koumprentziotis IA, Cawley A, Ewig E, Gérard AO, Labat M, Kami, Kubeczko M, Rapparini L, Starace M, Grafanaki K, Kamaratou M, Mavroudis D, Katoulis A, Nikolaou V, Heelan K, Koumaki D. PMID: 42804021 [PubMed - indexed for MEDLINE]
	Association of miR-199a-3p and CDK7 expression with clinicopathological features of breast cancer. Mol Biol Rep Ibrahim NA, Hidayat HJ. PMID: 42804014 [PubMed - indexed for MEDLINE]
	HER2 status change in residual breast carcinoma after neoadjuvant HER2-targeted therapy in patients with HER2-positive breast cancer. Breast Cancer Res Treat Raval P, Ding Q, Singh P, Alrohaibani A, Sun H, Ai D, Wanis KN, Zhao M, Chen H, Valero V, Chavez-MacGregor M, Sahin A. PMID: 42803995 [PubMed - indexed for MEDLINE]
	Geographic access to triple negative breast cancer clinical trials: are trials located near patients? Breast Cancer Res Treat Amin LB, Kirkwood MK, Levit LA, Balogh EP, Waterhouse DM, Unger JM, Garrett-Mayer E, Chavez-MacGregor M. PMID: 42803985 [PubMed - indexed for MEDLINE]
	[Update on ovarian cancer]. Pathologie (Heidelb) Wimberger P, Link T. PMID: 42803933 [PubMed - as supplied by publisher]
	Clinical and Local Immune Factors Associated With Pleurodesis Outcomes in Breast Cancer Patients With Malignant Pleural Effusion: A Retrospective Study. Am J Hosp Palliat Care Yoshino M, Horimoto Y, Oshi M, Yamada A, Ushiyama Y, Ueki Y, Ishizuka Y, Hayashi T, Ishikawa T, Watanabe J, Kutomi G. PMID: 42803570 [PubMed - as supplied by publisher]
	Ultrasound-Based Breast Cancer Diagnosis Using Scale-Aware Modulation Meet Deep Dilated Convolutional Network With Weighted-Leader Search Optimization. Ultrason Imaging V B, Arunachalam KP, V D, Giri Prasad R. PMID: 42803427 [PubMed - as supplied by publisher]
	Pathologic complete response and residual disease after neoadjuvant chemotherapy in breast cancer: Comparison of contrast-enhanced mammography, DCE-MRI, and Â¹â¸F-FDG PET/CT. Biomol Biomed Ozan Sanhal E, Mutlu , Sürer Budak E, Vural V, Zihni , Sim, Sezgin Göksu S, Ar. PMID: 42803352 [PubMed - as supplied by publisher]
	Molecular insights into triazole-based compounds for triple-negative breast cancer treatment. J Enzyme Inhib Med Chem Vilangalil A, E S SP, Bukke SPN, V S, Meha N, Thalluri C, Daniel K, Ahikiriza AA. PMID: 42803315 [PubMed - indexed for MEDLINE]
	The miR-877-3p polymorphism rs1264440 is associated with susceptibility to breast cancer. Ann Agric Environ Med Gong W, Yu M, Han J, Wang X, Mao X. PMID: 42802969 [PubMed - indexed for MEDLINE]
	18F-FDG PET/CT radiomics for prediction of BRCA mutations in high-grade serous ovarian cancer. Nucl Med Commun Jiang F, Liu S, Liu C, Zhang W, Liu X, Wu X, Xu J, Zou R. PMID: 42802904 [PubMed - as supplied by publisher]
	Perspectives of women and healthcare providers on facilitators and barriers to cervical cancer screening in the rural Kilimanjaro region Tanzania: a qualitative study. Glob Health Action Machange RF, Njau B, Mtuya CC, Katiti VW, Masika L, Mchome B, Kantelhardt E, Kaba M, Mmbaga BT, Mushi DL, Björling G, Manongi R. PMID: 42802903 [PubMed - indexed for MEDLINE]
	Isolated Ovarian Tuberculosis Mimicking Ovarian Malignancy in a Young Female with Primary Infertility: A Case Report. Int Med Case Rep J Sarwary MF, Sediqi M, Modabber MH, Kamal MI, Bawarzai A, Marofi M, Mukhlis AG, Sadeqy L. PMID: 42802860 [PubMed - indexed for MEDLINE]
	Sensitizing nanomedicine for platinum-resistant ovarian cancer. Nanomedicine (Lond) Lee DH, Lee W, Bach H. PMID: 42802703 [PubMed - as supplied by publisher]
	Mapping Breast Cancer Screening Publications in Palestine: A Scoping Review of Barriers and Facilitators. Psychooncology Yaish M, Khursani A, Althaher I, Hijazi M, Subeh H, Hanani A. PMID: 42802496 [PubMed - indexed for MEDLINE]
	NRF2-Regulated Ferroptosis in Breast Cancer: Mechanisms, Resistance, and Therapeutic Opportunities. Asia Pac J Clin Oncol Mohammad SI, Vasudevan A, Rodrigues SR, Turakulov R, R Baig M, Nematov O, Tailor NK, Singhal D, Nayak PP. PMID: 42802387 [PubMed - as supplied by publisher]
	Hereditary breast cancer: emerging roles of non-coding RNAs. Hereditas Yang Z, Guha D, Zhang L, Diao H, Bagchi A. PMID: 42802225 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 335734

Page 1 of 16787



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy